A Win For Harpoon Therapeutics, Inc.

Fri, Jun 03, 2022 at 05:30 PM
A Win For Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc. (HARP:NASDAQ) jumped higher at $2.4, a gain of 21.2%. On Thu, Jun 02, 2022, HARP:NASDAQ touched a New 2-Week Intraday Low of $1.92. The stock got featured on our News Catalysts scanner on Thu, May 26, 2022 at 05:46 PM in the 'BIOTECH' category. From Thu, May 19, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days

About Harpoon Therapeutics, Inc. (HARP:NASDAQ)

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.